Yahoo Finance

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North Augusta, South Carolina (USA) and Shanghai (China). With the acquisition, ...
Asian News International

Generic semaglutide race hinges on API supply as china leads, global peptide demand to hit 99,000 kg by 2030: Goldman Sachs

New Delhi [India], June 7 (ANI): The speed of semaglutide genericisation and GLP-1 pricing after 2031/32 will likely depend less on demand and more on peptide API manufacturing capacity, Goldman Sachs ...
TMCnet

Asahi Kasei's Novel Forward Osmosis-Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time

Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei's novel forward osmosis-membrane distillation (FO-MD) system into its facility ...
C&EN

Next-Generation Peptide Manufacturing: Green Chemistry and Sustainable Development via LPPS, Continuous-Flow, and Integrated Platforms

Peptides, as essential biomolecules linking amino acids and proteins, play a vital role across numerous disciplines, including life science research, drug discovery, biomaterials engineering, and ...
Mena FN

Cordenpharma Acquires Ambiopharm To Expand Global Peptide API Capacity

Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into an agreement to acquire AmbioPharm, a ...